PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Ethyl pyruvate protects against blood-brain barrier damage and improves long-term neurological outcomes in a rat model of traumatic brain injury.

Rat / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25533312 ↗2014Reported benefit

Ethyl pyruvate protects against blood-brain barrier damage and improves long-term neurological outcomes in a rat model of traumatic brain injury.

RatTBIControlled cortical impactSprague-DawleyMalen = n=10 per group for behaviour, histology and dose-finding; n…Intraperitoneal30 mg/kg (dose-finding used 10, 30 and 50 mg/kg)First dose 15 minutes after controlled cortical impact

Model: Unilateral controlled cortical impact, 5 mm flat tip, 3.2 mm depth, 0.5 s dwell, 4.0 m/s velocity, via 5.4 mm right parietal craniotomy; sham craniotomy controls

Ethyl pyruvate 30 mg/kg improved sensorimotor and cognitive performance and reduced tissue loss to 28 days, and at 48 hours reduced blood-brain barrier permeability, oedema, MMP-9 activity, tight junction degradation and neuroinflammation.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.